Attached files
Exhibit 32.1
CERTIFICATION
In
connection with the quarterly report of Cellular Biomedicine
Group, Inc. (the “Company”) on Form 10-Q for
the quarter ended March 31, 2020, as filed with the Securities and
Exchange Commission (the “Report”), I, Tony (Bizuo)
Liu, Chief Executive Officer and Chief Financial Officer (Principal
Executive Officer and Principal Financial and Accounting Officer)
of the Company, hereby certify as of the date hereof, solely for
purposes of Title 18, Chapter 63, Section 1350 of the United
States Code, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my
knowledge:
(1) The
Report fully complies with the requirements of
Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934, and
(2) The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company at the dates and for the periods
indicated.
A
signed original of this written statement required by Section 906
has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or
its staff upon request.
|
|
|
|
Date:
May 6, 2020
|
By:
|
/s/ Tony
(Bizuo) Liu
|
|
|
|
Tony
(Bizuo) Liu
|
|
|
|
Chief
Executive Officer and Chief Financial Officer
|
|
|
|
(Principal
Executive Officer and Principal Financial and Accounting
Officer)
|
|
|
|
|
|
|
|
|
|
|
|
|
|